Dr. Rémi Quirion
Fellow
Current Employer
McGill University
Election Year
2003
Academy
Académie des sciences
Discipline
Medical Sciences
Department
CIHR Institute of Neurosciences, Mental Health and Addiction
Keywords
Neuropharmacology, neurosciences, Alzheimer's Disease, mental health, molecular biology
LONG
Rémi Quirion is an internationally recognized neuroscientist. He is a world leader in the study of Alzheimer's disease and of the biology of neuropeptides. His discoveries include the identification of major interactions between key abnormalities of the Alzheimer brain, elucidation of the roles of neuropeptide Y in depression, and definition of the function of peptide CGRP in pain and morphine tolerance. The author of more than 500 publications and one of the few most highly cited Canadian neuroscientists, Dr. Quirion has received numerous prizes including the Galien Award for his research. He is the inaugural Scientific Director of the Institute of Neurosciences, Mental Health and Addiction of CIHR.
SHORT
Rémi Quirion is an internationally recognized neuroscientist and a world leader in the study of Alzheimer's disease and of the biology of neuropeptides. His discoveries include the identification of major interactions between key abnormalities of the Alzheimer brain, elucidation of the roles of neuropeptide Y in depression, and definition of the function of peptide CGRP in pain and morphine tolerance.
Rémi Quirion is an internationally recognized neuroscientist. He is a world leader in the study of Alzheimer's disease and of the biology of neuropeptides. His discoveries include the identification of major interactions between key abnormalities of the Alzheimer brain, elucidation of the roles of neuropeptide Y in depression, and definition of the function of peptide CGRP in pain and morphine tolerance. The author of more than 500 publications and one of the few most highly cited Canadian neuroscientists, Dr. Quirion has received numerous prizes including the Galien Award for his research. He is the inaugural Scientific Director of the Institute of Neurosciences, Mental Health and Addiction of CIHR.
SHORT
Rémi Quirion is an internationally recognized neuroscientist and a world leader in the study of Alzheimer's disease and of the biology of neuropeptides. His discoveries include the identification of major interactions between key abnormalities of the Alzheimer brain, elucidation of the roles of neuropeptide Y in depression, and definition of the function of peptide CGRP in pain and morphine tolerance.